NCT03903107

Brief Summary

The goal of this study is to assess the feasibility, accuracy and safety of performing fluoroless (or low fluoro) conduction system pacing utilizing electro-anatomic mapping (EAM) with the CARTO 3 mapping system (Biosense Webster Inc, Irvine, CA) in comparison to a group of patients undergoing conventional conduction system pacing (CSP) Implants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2018

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 4, 2019

Completed
1.6 years until next milestone

Study Start

First participant enrolled

October 26, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

October 31, 2018

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Success of achieving CSP

    Feasibility of achieving a successful CSP implant at the His Bundle or Left Bundle branch with low or zero Fluoroscopy. This will result in low to no fluoroscopy exposure for both the subject and the operator, as well as shorter procedure times.This will be documented during procedure.

    Intra-procedure

Secondary Outcomes (3)

  • Total radiation exposure time during procedure

    Intra-procedure

  • Procedure-related complications

    30 days post procedure

  • Need for His Lead revisions

    for a period of 6 months post procedure

Study Arms (2)

Conventional Conduction System Pacing(CSP) using fluoroscopy

PLACEBO COMPARATOR

Subjects in this arm will receive Conduction System Pacing(CSP) using conventional fluoroscopy technique.

Procedure: Conventional fluoroscopy guided Conduction System Pacing(CSP)

Fluoroless Conduction System Pacing(CSP) utilizing EAM with the CARTO 3 mapping system

EXPERIMENTAL

Subjects in this arm will receive Conduction System Pacing(CSP) utilizing electroanatomic mapping system to eliminate or minimize fluoroscopic exposure.

Procedure: Electroanatomic Mapping (Fluoroless) guided Conduction System Pacing(CSP)

Interventions

conventional standard approach Conduction System Pacing(CSP) using fluoroscopy

Conventional Conduction System Pacing(CSP) using fluoroscopy

Conduction System Pacing(CSP) using electroanatomic mapping system with no or minimal fluoroscopy

Fluoroless Conduction System Pacing(CSP) utilizing EAM with the CARTO 3 mapping system

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Indication for Permanent Pacemaker implantation or implantation of Cardiac Resynchronization Therapy Device

You may not qualify if:

  • Existing cardiac device including Pacemaker or Cardiac Resynchronization Therapy device
  • Inability of patient capacity to provide consent for themselves either due to medical or psychiatric comorbidity
  • Pregnancy
  • Difficulty with follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

Related Publications (1)

  • Sharma PS, Huang HD, Trohman RG, Naperkowski A, Ellenbogen KA, Vijayaraman P. Low Fluoroscopy Permanent His Bundle Pacing Using Electroanatomic Mapping: A Feasibility Study. Circ Arrhythm Electrophysiol. 2019 Feb;12(2):e006967. doi: 10.1161/CIRCEP.118.006967.

MeSH Terms

Conditions

Sick Sinus SyndromeAtrioventricular BlockHeart Failure, Systolic

Condition Hierarchy (Ancestors)

Arrhythmia, SinusArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesHeart BlockCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsHeart Failure

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: CSP can be achieved successfully and safely utilizing electro-anatomic mapping (EAM) with the CARTO 3mapping system
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2018

First Posted

April 4, 2019

Study Start

October 26, 2020

Primary Completion

April 1, 2021

Study Completion

September 30, 2024

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations